Active substances
Naphazoline + Pheniramine
- SFDA 1
- US FDA 5
- Health Canada 3
- US price lines 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| NAPHCON-A EYE DROPS | 3,0.025 %,% | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 17.25 | NCE · OTC | ALCON N.V. | Valid |
Indications — CHI Daman Drug Formulary
ALLERGIC CONJUCTIVITIS (AC); ALLERGIC RHINITIS; ALLERGIC RHINITIS-ALLERGIC RHINO-CONJUNCTIVITIS; VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| OPCON-A | 0.02675%;0.315% | solution/drops · ophthalmic | BAUSCH AND LOMB | Over-the-counter | 8 Jun 1994 |
| NAPHCON-A | 0.025%;0.3% | solution/drops · ophthalmic | ALCON | Over-the-counter | 8 Jun 1994 |
| VISINE | 0.025%;0.3% | solution/drops · ophthalmic | KENVUE BRANDS | Over-the-counter | 31 Jan 1996 |
| NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | 0.02675%;0.315% | solution/drops · ophthalmic | ALTAIRE PHARMS INC | Over-the-counter | 27 Sep 2010 |
| NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | 0.025%;0.3% | solution/drops · ophthalmic | RISING | Over-the-counter | 24 Jan 2013 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| NAPHCON A | 00481408 | 0.025 %; 0.3 % | SOLUTION · OPHTHALMIC | ALCON CANADA INC |
| SOOTHE ALLERGY | 00750794 | 0.315 % / W/V; 0.02675 % / W/V | DROPS · OPHTHALMIC | BAUSCH & LOMB INC |
| VISINE FOR ALLERGY WITH ANTIHISTAMINE | 02242764 | 0.025 % / W/V; 0.3 % / W/V | DROPS · OPHTHALMIC | JOHNSON & JOHNSON INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | NAPHCON-A EYE DROPS | $0.55744 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.